Anti-MITF antibody conjugated liposomes serve as a targeted delivery system for therapies aimed at melanoma, focusing on the microphthalmia-associated transcription factor (MITF). By directing the liposomes to MITF-expressing melanoma cells, they improve drug concentration at the site of action. This strategy enhances efficacy while reducing toxicities associated with systemic treatment. Ultimately, it holds potential for improving patient outcomes in melanoma therapy.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
BRD-0362MZ | Chicken Anti-MITF Polyclonal IgY | WB | Chicken antibody |
There are currently no Customer reviews or questions for VS-1024-FY192. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.